drugset / Trial / NCT02148016

Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation

NCT02148016

Phase 1/2 Unknown 30 enrolled Sun Yat-sen University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Corneal disease is a leading cause of blindness in the world. A shortage of corneal donor tissue has prevented many patients from regaining vision. Additionally, refractive error such as myopia is a major cause of impaired visual function worldwide. Although refractive error is correctable by procedures that modify the refractive power of the cornea, these procedures often weaken corneal integrity and have risk of complications. This study aims to evaluate the safety and efficacy of corneal surface epithelium repair and regeneration in the treatment of corneal surface diseases and refractive error using autologous limbal stem cell transplantation.

Timeline

Start
2012-12
Primary completion
2014-06
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Limbal stem cells (LSCs) Cell therapy
Background Betamethasone Other / unclassified
Background Levofloxacin Small molecule

Indications